Is US FDA Following Correct Precedent With UniQure Gene Therapy Randomized Trial Demand?

 
• By Sue Sutter and Bridget Silverman
  
Huntington's disease
The FDA said it is following Huntington's disease precedent in requesting a randomized, controlled trial for uniQure's gene therapy. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Approval Standards